Marc Gigante

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma

An Zhao, Guorong Li, Michel Péoc’h et al. · Experimental and Molecular Pathology · 2012 · 156 citations

Medicine, Molecular Medicine, Oncology +14

Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population

Y. Neuzillet, X. Tillou, Romain Mathiéu et al. · European Urology · 2011 · 99 citations

Medicine, Oncology, Pathology +11

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Marc Gigante, Y. Neuzillet, Jean‐Jacques Patard et al. · British Journal of Urology · 2012 · 56 citations

Medicine, Nephrology, Urology +17

Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.

Marc Gigante, Guorong Li, Céline Ferlay et al. · PubMed · 2012 · 27 citations

Medicine, Oncology, Genitourinary Oncology +16

Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma.

Guorong Li, Grégory Badin, An Zhao et al. · PubMed · 2013 · 22 citations

Medicine, Oncology, Pathology +17